InnovationMap · Jul 2026
Local coverage of the Series A and TYBR's B3 GEL commercialization plans, including comments on the product's fit with existing surgical workflows.
Natural hydrogel to keep internal organs scar-free after surgery
Company research
Public company, workplace, funding, and market signals
Overview
Houston-based medical technology / regenerative medicine startup developing the B3 GEL™ System, a flowable ECM hydrogel used to protect healing soft tissues after surgery and reduce post-surgical tethering/scar formation.
Primary product
B3 GEL™ System
Founded
2020
Headquarters
Houston, Texas, United States
Team size
1-10 employees
Work style
Onsite
Industry
Medical Equipment Manufacturing
Sub-industry
Medical technology / regenerative medicine
Offices
2450 Holcombe Blvd Suite X, Houston, TX 77021, United States (HQ)
Open Positions
0 jobs at TYBR Health
No open positions
Check back later for new openings